Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 09-2010 | 09-2009 | |
| Sales | 2,340 | 1,140 | 0 | 1,156,600 | 990,200 |
| Cost of Goods | N/A | N/A | N/A | 738,700 | 663,000 |
| Gross Profit | 2,340 | 1,140 | N/A | 417,900 | 327,200 |
| Operating Expenses | 121,739 | 127,081 | 0 | 372,700 | 743,900 |
| Operating Income | -119,399 | -125,941 | N/A | 45,900 | -416,700 |
| Interest Expense | 156 | 0 | 0 | 0 | 0 |
| Other Income | 3,653 | 3,069 | 0 | 39,700 | -39,300 |
| Pre-tax Income | -115,902 | -122,872 | 0 | 85,600 | -456,000 |
| Income Tax | 582 | 224 | N/A | 7,100 | -3,100 |
| Net Income Continuous | -116,484 | -123,096 | N/A | 78,500 | -452,900 |
| Net Income Discontinuous | N/A | N/A | N/A | -15,200 | -22,700 |
| Minority Interests | N/A | N/A | N/A | 1,300 | -1,300 |
| Net Income | $-116,484 | $-123,096 | $N/A | $62,000 | $-474,300 |
| EPS Basic Total Ops | -2.36 | -2.64 | N/A | 0.64 | -4.87 |
| EPS Basic Continuous Ops | -2.36 | -2.64 | N/A | 0.80 | -4.64 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.16 | -0.23 |
| EPS Diluted Total Ops | -2.36 | -2.64 | N/A | 0.63 | -4.87 |
| EPS Diluted Continuous Ops | -2.36 | -2.64 | N/A | 0.78 | -4.64 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.15 | -0.23 |
| EPS Diluted Before Non-Recurring Items | -2.36 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-117,753 | $-125,201 | $N/A | $109,700 | $60,000 |